Effect of omega-3 fatty acids supplementation on serum levels of malondialdehyde, total antioxidant capacity and paraoxonase1 in polycystic ovary syndrome patients
Phase 2
- Conditions
- polycystic ovary syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT201106243664N5
- Lead Sponsor
- utritional Research Center,Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
woman with polycystic ovary syndrome; 20-35 years old and BMI=25-40; Exclusion criteria: Thyroid disorders; hyperprolactinemia; cushing syndrome; liver,kidney and cardiovascular disease; diabetes; pregnancy and lactation; smoking; use of anti obesity drugs; lipid lowering agent; glucocorticids; anti coagulation drugs; use a lowering weight diet; have a usual sports program; receiving omega-3 supplement during 2 month ago and receiving any nutritional supplements during the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Malondialdehyde(MDA). Timepoint: baseline and at the end of intervention. Method of measurement: Fluorimetry method.
- Secondary Outcome Measures
Name Time Method Total antioxidant capacity. Timepoint: baseline and at the end of intervention. Method of measurement: FRAP.;Paraxonase1(PON1). Timepoint: baseline and at the end of intervention. Method of measurement: Spectrophotometry.